0000000000613229

AUTHOR

P. Valagussa

showing 2 related works from this author

Overall survival impact of BEACOPP versus ABVD in advanced hodgkin lymphoma: a pooled analysis of 4 randomized trials

2016

IF 6.671; International audience

[SDV.MHEP.HEM] Life Sciences [q-bio]/Human health and pathology/HematologySurvival impact[ SDV.MHEP.HEM ] Life Sciences [q-bio]/Human health and pathology/HematologyABVD[SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/HematologyHodgkin lymphomaBEACOPPChimiothérapie
researchProduct

Association of derived neutrophil-to-lymphocyte ratio (dNLR) with pathological complete response (pCR) after neoadjuvant chemotherapy (CT)

2019

Abstract Background dNLR is a novel biomarker associated with clinical outcome in solid tumors including early stage breast cancer (BC). Here we report the association of dNLR with pCR in triple-negative (TN) and luminal BC patients (pts) treated with neoadjuvant CT. Methods This was a retrospective analysis of two randomized studies (GEICAM/2006-03 - NCT00432172 and ETNA - NCT01822314) involving 821 pts with early stage (>2cm) or locally advanced TN or luminal BC receiving anthracycline/taxane-based CT +/- carboplatin (GEICAM/2006-03) or nab-paclitaxel/paclitaxel followed by anthracycline regimen (ETNA). dNLR was calculated as the ratio of neutrophils and the difference between total leuko…

Anthracycline Antibioticsmedicine.medical_specialtybusiness.industryLocally advancedHematologyBreast cancer stage iPeripheral bloodInterval dataContinuous variableOncologyFamily medicineRetrospective analysisMedicinebusinesshealth care economics and organizationsComplete responseAnnals of Oncology
researchProduct